Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon

被引:2
|
作者
Springer, Rachel [1 ]
Marino, Miguel [1 ,3 ]
Bailey, Steffani R. [1 ]
Angier, Heather [1 ]
O'Malley, Jean P. [1 ,2 ]
Hoopes, Megan [2 ]
Lindner, Stephan [3 ,4 ]
DeVoe, Jennifer E. [1 ,2 ]
Huguet, Nathalie [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Family Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA
[2] OCHIN, Portland, OR USA
[3] Portland State Univ, Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA
[4] Oregon Hlth & Sci Univ, Ctr Hlth Syst Effectiveness, Portland, OR 97201 USA
基金
美国医疗保健研究与质量局;
关键词
Affordable care act; Medicaid; medication-assisted treatment; opioid epidemic; opioid use disorder; prescribed opioid use; UNITED-STATES; CHRONIC PAIN; BUPRENORPHINE; ABUSE; ANALGESICS; DURATION; THERAPY;
D O I
10.1111/add.14667
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background/Aims Evidence suggests that Medicaid beneficiaries in the United States are prescribed opioids more frequently than are people who are privately insured, but little is known about opioid prescribing patterns among Medicaid enrollees who gained coverage via the Affordable Care Act Medicaid expansions. This study compared the prevalence of receipt of opioid prescriptions and opioid use disorder (OUD), along with time from OUD diagnosis to medication-assisted treatment (MAT) receipt between Oregon residents who had been continuously insured by Medicaid, were newly insured after Medicaid expansion in 2014 or returned to Medicaid coverage after expansion. Design Cross-sectional study using inverse-propensity weights to adjust for differences among insurance groups. Setting Oregon. Participants A total of 225 295 Oregon Medicaid adult beneficiaries insured during 2014-15 and either: (1) newly enrolled, (2) returning in 2014 after a > 12-month gap or (3) continuously insured between 2013 and 2015. We excluded patients in hospice care or with cancer diagnoses. Measurements Any opioid-dispensed, chronic (> 90-days) and high-dose (> 90 daily morphine milligram equivalence) opioid use, documented OUD diagnosis and MAT receipt. Findings Compared with the continuously insured, newly and returning insured enrollees were less likely to be dispensed opioids [newly: 42.3%, 95% confidence interval (CI) = 42.0-42.7%; returning: 49.3%, 95% CI = 48.8-49.7%; continuously: 52.5%, 95% CI = 52.0-53.0%], use opioids chronically (newly: 12.8%, 95% CI = 12.4-13.1%; returning: 11.9%, 95% CI = 11.5-12.3%, continuously: 15.8%, 95% CI = 15.4-16.2%), have OUD diagnoses (newly: 3.6%, 95% CI = 3.4-3.7%; returning: 3.9%, 95% CI = 3.8-4.1%, continuously: 4.7%, 95% CI = 4.5-4.9%) and receive MAT after OUD diagnosis [hazard ratio newly: 0.57, 95% CI = 0.53-0.61; hazard ratio returning: 0.60, 95% CI = 0.56-0.65 (ref: continuously)]. Conclusions Residents of Oregon, United States who enrolled or re-enrolled in Medicaid health insurance after expansion of coverage in 2014 as a result of the Affordable Care Act were less likely than those already covered to receive opioids, use them chronically or receive medication-assisted treatment for opioid use disorder.
引用
收藏
页码:1775 / 1784
页数:10
相关论文
共 50 条
  • [1] Associations Between Polysubstance Use Patterns and Receipt of Medications for Opioid Use Disorder Among Adults in Treatment for Opioid Use Disorder
    Ford, Becky R.
    Bart, Gavin
    Grahan, Brian
    Shearer, Riley D.
    Winkelman, Tyler N. A.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 159 - 162
  • [2] Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment
    Wen, Hefei
    Hockenberry, Jason M.
    Borders, Tyrone F.
    Druss, Benjamin G.
    MEDICAL CARE, 2017, 55 (04) : 336 - 341
  • [3] Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis
    Dennis McCarty
    Yifan Gu
    John W. McIlveen
    Bonnie K. Lind
    Addiction Science & Clinical Practice, 14
  • [4] Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis
    McCarty, Dennis
    Gu, Yifan
    McIlveen, John W.
    Lind, Bonnie K.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2019, 14 (01) : 31
  • [5] Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
    Yang, Justin C.
    Roman-Urrestarazu, Andres
    Brayne, Carol
    PLOS ONE, 2019, 14 (12):
  • [6] Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System
    Abraham, Amanda J.
    Yarbrough, Courtney R.
    Harris, Samantha J.
    Adams, Grace Bagwell
    Andrews, Christina M.
    PSYCHIATRIC SERVICES, 2021, 72 (02) : 148 - 155
  • [7] Mental health and substance use disorder comorbidities among Medicaid beneficiaries: Associations with opioid use disorder and prescription opioid misuse
    Swartz, James A.
    Franceschini, Dana
    Scamperle, Kamryn
    AIMS PUBLIC HEALTH, 2023, 10 (03): : 658 - 677
  • [8] Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorder
    Varisco, Tyler
    Shen, Chan
    Thornton, Douglas
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 117
  • [9] PRESCRIPTION OPIOID USE BEFORE AND AFTER AN OVERDOSE EVENT IN MISSISSIPPI MEDICAID
    Inguva, S.
    Gangan, N.
    Pittman, E.
    Banahan, B., III
    Noble, S.
    VALUE IN HEALTH, 2018, 21 : S261 - S261
  • [10] Treatment of Prescription Opioid Use Disorder in Pregnant Women
    Guille, Constance
    Barth, Kelly S.
    Mateus, Julio
    McCauley, Jenna L.
    Brady, Kathleen T.
    AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (03): : 208 - 214